| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/13/2002 | WO2002045724A2 Use of modified mammalian blood for treating transforming growth factor related diseases |
| 06/13/2002 | WO2002045723A2 Inflammatory cytokine secretion inhibition with modified mammalian blood |
| 06/13/2002 | WO2002045569A2 Method for precipitating red blood cells |
| 06/13/2002 | WO2002029010A3 Method for obtaining in vitro mammal islet cells and uses thereof |
| 06/13/2002 | WO2002024224A3 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen |
| 06/13/2002 | WO2002014357A3 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 06/13/2002 | WO2002008263A3 Modified virus having an altered tropism |
| 06/13/2002 | WO2001091775A3 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 06/13/2002 | WO2001072277A3 Immunotherapeutic methods and compositions |
| 06/13/2002 | WO2001068828A3 Compositions and methods for regulated protein expression in gut |
| 06/13/2002 | WO2001042461A3 Apoptin-associating protein |
| 06/13/2002 | WO2000061736A9 Recombinant and mutant marek's disease virus |
| 06/13/2002 | US20020073439 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease |
| 06/13/2002 | US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen |
| 06/13/2002 | US20020072120 Helper viruses for the preparation of recombinant viral vectors |
| 06/13/2002 | US20020072119 Preventing tumor growth; obtain cells, transform with expression vector, monitor cells for reduction in cell proliferation |
| 06/13/2002 | US20020072117 Human feeder cells that support proliferation of undifferentiated pluripotent stem cells |
| 06/13/2002 | US20020072115 Pancreatic islet cell growth factors |
| 06/13/2002 | US20020071878 Anti proliferative preparations |
| 06/13/2002 | US20020071862 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions, and kit related thereto |
| 06/13/2002 | US20020071853 Cosmetic products compatible with cutaneous ecology and methods for their use |
| 06/13/2002 | US20020071849 A41L protein or a chemokine-binding fragment thereof; detecting an interaction of the chemokine-binding molecule with a chemokine; antiinflammatory agents |
| 06/13/2002 | US20020071835 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 06/13/2002 | US20020071833 Hematopoietic stem cell gene therapy |
| 06/13/2002 | US20020071832 Use of mutant herpes viruses and anticancer agents in the treatment of cancer |
| 06/13/2002 | US20020071829 Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 06/13/2002 | US20020071828 Biocompatible cuff into which a system for expressing a neurotrophic factor is introduced. |
| 06/13/2002 | US20020071827 Bone graft substitute composition |
| 06/13/2002 | DE10061334A1 Verwendung von aus embryonalen Stammzellen hergeleiteten Zellen zur Erhöhung der Transplantationstoleranz und zur Wiederherstellung zerstörten Gewebes Using derived from embryonic stem cells to increase transplant tolerance and restore damaged tissue |
| 06/13/2002 | CA2678490A1 Isolated placental perfusate and placental cells isolated therefrom |
| 06/13/2002 | CA2431193A1 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/13/2002 | CA2430989A1 Method of collecting placental stem cells |
| 06/13/2002 | CA2430937A1 Inflammatory cytokine secretion inhibition |
| 06/13/2002 | CA2430771A1 Dehydrated antigen presenting cells usable for vaccination |
| 06/13/2002 | CA2430723A1 Method for precipitating red blood cells |
| 06/13/2002 | CA2430716A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | CA2429769A1 Methods of treatment involving human mda-7 |
| 06/13/2002 | CA2428092A1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 06/13/2002 | CA2427615A1 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 06/13/2002 | CA2425396A1 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/12/2002 | EP1213032A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/12/2002 | EP1213023A1 Kit comprising reovirus |
| 06/12/2002 | EP1212428A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 06/12/2002 | EP1212420A1 Conditional immortalisation of cells |
| 06/12/2002 | EP1212405A2 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 06/12/2002 | EP1212404A2 Isolation of muscle-derived stem cells and uses therefore |
| 06/12/2002 | EP1212403A1 Method for treatment of beta-hemoglobinopathies |
| 06/12/2002 | EP1212359A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 06/12/2002 | EP1212358A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212093A2 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 06/12/2002 | EP1212083A1 Oral recombinant lactobacilli vaccines |
| 06/12/2002 | EP1212076A2 Stimulation of sperm function |
| 06/12/2002 | EP1212069A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 06/12/2002 | EP1212066A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 06/12/2002 | EP1211931A1 A knockout mouse for the tumor suppressor gene anx7 |
| 06/12/2002 | EP1107771B1 Homeopathic medicine comprising one or several mother-of-pearl constituents including bio-aragonite |
| 06/12/2002 | EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 06/12/2002 | EP1018884A4 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS |
| 06/12/2002 | EP0989855A4 Osteoarthritis cartilage regeneration using human mesenchymal stem cells |
| 06/12/2002 | EP0914416B1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors |
| 06/12/2002 | EP0817833B1 Filter device |
| 06/12/2002 | EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules |
| 06/12/2002 | CN1353764A Method for selecting improved vectors |
| 06/12/2002 | CN1353575A i(in Vitro) induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 06/12/2002 | CN1353183A Establishing recombinant strain of BCG vaccine and its application |
| 06/12/2002 | CN1352989A Medical wine 'Sansan' for treating hyperosteogeny |
| 06/12/2002 | CN1352983A Chinese medicine for treating hypertension |
| 06/12/2002 | CN1352978A Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process |
| 06/12/2002 | CN1352970A Chinese patent medicine for treating colitis |
| 06/12/2002 | CN1352969A Universal surgical plaster |
| 06/12/2002 | CN1352964A Powdered medicine for treating pulmonary tuberculosis |
| 06/12/2002 | CN1352963A Blood pressure stabilizing pill |
| 06/12/2002 | CN1352961A Mongolian medicine prepared by enzyme engineering for treating bone injury and its preparing process |
| 06/12/2002 | CN1352958A Chinese Medicine for treating disease and improving intelligence |
| 06/12/2002 | CN1086144C Capsule for tonifying kidney |
| 06/12/2002 | CN1086141C Medicine for treating early-stage hepatocirrhosis and its preparing process |
| 06/12/2002 | CN1086139C Chinese patent medicine for curing hepatitis B |
| 06/12/2002 | CN1086138C Chinese patent medicine for curing myopia |
| 06/12/2002 | CN1086137C Chinese patent medicine for curing senile cataract |
| 06/12/2002 | CN1086133C Medicine for treating angitis |
| 06/12/2002 | CN1086132C Traditional Chinese medicinal pill for transforming calculus, eliminating toxin and antitumour |
| 06/12/2002 | CN1086130C Chinese medicine composition for treating scabies, and method for preparing same |
| 06/12/2002 | CN1086129C Medicine for treating hepatitis |
| 06/12/2002 | CN1086128C Chinese medicine preparation for preventing and curing cerebral thrombus |
| 06/11/2002 | US6403560 Extracting hyaluronic acid together with a protein from chicken comb, mammalian skin or mammalian organ; |
| 06/11/2002 | US6403370 Generation an infection, reproduction, genetic engineering |
| 06/11/2002 | US6403359 Deactivation electrophiles |
| 06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
| 06/11/2002 | US6403124 Storage and maintenance of blood products including red blood cells and platelets |
| 06/11/2002 | US6403117 Archaesomes, archaeosomes containing coenzyme Q10 and other types of liposomes containing coenzyme Q10 adjuvants and as delivery vehicles |
| 06/11/2002 | US6403095 Treatment of primary and metastatic neoplastic diseases with HSP70-peptide complexes |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403083 Antitumor, anticancer agents; mixture containing mycelium and carrier |
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |